J. Vitoux

发表

Adjusted Versus Fixed Doses of the Low-Molecular-Weight Heparin Fragmin in the Treatment of Deep Vein Thrombosis

M. Alhenc-Gelas, J. Fiessinger, M. Aiach, 1994, Thrombosis and Haemostasis.

Heparin cofactor II in patients with deep venous thrombosis under heparin and oral anticoagulant therapy.

J. Fiessinger, M. Aiach, P. Toulon, 1988, Thrombosis research.

[The value of D-dimer assays in the emergency diagnosis of venous thrombosis].

J. Fiessinger, M. Aiach, S. Gandrille, 1990, Presse medicale.

Acute peripheral arterial and graft occlusion: treatment with selective infusion of urokinase and lysyl plasminogen.

J. Gaux, J. Fiessinger, C. Angel, 1986, Radiology.

Heparin cofactor II: an acute phase reactant in patients with deep vein thrombosis

J. Fiessinger, M. Aiach, D. Sicard, 1991, Blood Coagulation and Fibrinolysis.

[Treatment of deep venous thrombosis. Comparative study of a low molecular weight heparin fragment (Fragmin) by the subcutaneous route and standard heparin by the continuous intravenous route. A multicenter study].

B. Polack, J. Fiessinger, B. Boneu, 1989, La Revue de medecine interne.

Heparin-induced thrombocytopenia and pentosan polysulfate: treatment with a low molecular weight heparin despite in vitro platelet aggregation.

J. Fiessinger, M. Aiach, J. Vitoux, 1986, Thrombosis and haemostasis.

Low-Molecular-Weight Heparin for Deep Venous Thrombosis-Reply

J. Fiessinger, M. Aiach, J. Vitoux, 1988 .

High total and free protein S in patients with acute deep vein thrombosis.

J. Fiessinger, Y. Sultan, M. Aiach, 1990, Thrombosis research.

[Radioimmunoassay of plasma arginine-vasopressin in the cirrhotic patient. 15 patients].

S. Guillemant, J. Vitoux, P. Desgrez, 1978, La Nouvelle presse medicale.

Should Thromboprophylactic Dosage of Low Molecular Weight Heparin Be Adapted to Patient’s Weight?

J. Fiessinger, M. Aiach, J. Vitoux, 1988, Thrombosis and Haemostasis.

Local thrombolysis in peripheral arteries and bypass grafts.

J. Gaux, J. Fiessinger, P. Brénot, 1987, Journal of vascular surgery.

[Trichinosis of the central nervous system. One case (author's transl)].

J. Hauw, F. Lhermitte, R. Escourolle, 1982, La Nouvelle presse medicale.

Circulating Activities During Constant Infusion of Heparin or a Low Molecular Weight Derivative (Enoxaparine): Failure to Demonstrate any Circadian Variations

J. Fiessinger, C. Leroy, M. Aiach, 1987, Thrombosis and Haemostasis.

Heparin-Associated Thrombocytopenia Treatment with Low Molecular Weight Heparin

J. Fiessinger, M. Aiach, J. Vitoux, 1986, Thrombosis and Haemostasis.

[Thrombolytic treatment of arteriopathies. Do thrombolytics compete with surgery?].

J. Gaux, J. Fiessinger, M. Aiach, 1986, Haemostasis.

[Anticoagulant treatment with fluindione. Relation between the decrease of vitamin K-dependent factors and blood fluindione].

J. Fiessinger, M. Aiach, J. Alexandre, 1986, Therapie.

[Acute polymyositis with spontaneously regressive subcutaneous edema. Apropos of a case].

C. Duyckaerts, P. Bouche, M. Chaunu, 1985, Revue neurologique.